Ibsa Institut Biochimique Sa competitive analysis

Explore patent oppositions filed by Ibsa Institut Biochimique Sa against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 19, 2026
Patent NumberTitleApplicantOpposition Date
Cystitis Treatment With High Dose Chondroitin SulfateARALEZ PHARMACEUTICALS CANADAJul 23, 2015

Explore Ibsa Institut Biochimique Sa's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 19, 2026
Patent NumberPublication DateTitleTotal Oppositions
Feb 11, 2026Injectable Mixtures Of Hyaluronic Acid For Use In Dermo-Aesthetics1

Latest PTAB cases involving Ibsa Institut Biochimique Sa

Discover the latest PTAB cases involving Ibsa Institut Biochimique Sa, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ibsa Institut Biochimique Sa with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 19, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
IBSA INSTITUT BIOCHIMIQUE11 - -
ARALEZ PHARMACEUTICALS CANADA - 2 - -
SKM2 - - -
STELLAR - 2 - 8